Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Cardiology
    • End of Life
    • Gastroentrology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Nephrology
    • Neurology
    • Oncology
    • Ophthalmology
    • Opioids
    • Rare Diseases
    • Women’s Health
  • RESOURCES
  • CONTACT

Ace the Case: Current Therapeutic Targets in CKD Anemia (Part 2 of 3)

  • Post author By AME
  • Post date August 18, 2022

Ace the Case: Current Therapeutic Targets in CKD Anemia (Part 2 of 3)

 Nephrology

0.25 / AMA PRA Category 1 Credit™
0.25 / ABIM MOC Points
0.25 / ACPE contact hours

  • Listing ID: 1879
← Ace the Case: Symptomatic Anemia (Part 3 of 3) → DOACs and Patients with Malignancies (Part 3 of 3)